Opioid use patterns and persistent use after hemodialysis access surgery
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2025.05.207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Timothy P Copeland und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of California, San Francisco, CA. Electronic address: timothy.copeland@ucsf.edu. Hauptthemen laut MEDLINE: Analgesics, Opioid, Renal Dialysis, Kidney Failure, Chronic, Practice Patterns, Physicians'. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences, Clinical and Translational Science Institute, University of California, Los Angeles.
Abstract (Originalsprache)
OBJECTIVE: We evaluated the risk of persistent opioid use related to opioid pain management for hemodialysis access creation and identify patterns of opioid dosage and use. METHODS: This retrospective cohort study included Medicare-enrolled opioid-naïve patients in the US Renal Data System who initiated hemodialysis for end-stage kidney disease between April 2015 and June 2019. Persistent opioid use was defined as an opioid prescription 90 to 180 days after surgery. The Cox proportional hazards model used censored patients at the time of hospitalization, subsequent hemodialysis access procedures, death, and end of Medicare enrollment. A mixed-effect logistic regression modeled opioid prescription, and a mixed-effect linear regression modeled opioid quantity in 5-mg hydrocodone equivalents. RESULTS: A total of 28,404 patients (median age, 72 years; 25th, 75th percentile, 66, 79 years; 15,322 men [53.9%]) underwent index access creation, of whom 14,265 patients filled an opioid prescription at access creation (50.2%), with 3289 opioid prescriptions (23.1%) for ≥42 tablets of 5-mg hydrocodone equivalents (ie, ≥2 weeks prescription). Patients receiving ≥42 tablets of 5-mg hydrocodone equivalents (≥2 weeks) had 1.28 times the risk of persistent opioid use (95% confidence interval, 1.08-1.52) relative to those who did not fill an opioid prescription. In contrast, receipt of 20 or fewer tablets of 5-mg hydrocodone equivalents was not associated with an increased risk of persistent opioid use (hazard ratio 1.00; 95% confidence interval, 0.85-1.18). CONCLUSIONS: Given the risk of persistent opioid use stemming from hemodialysis access procedures, the development of formal recommendations for conservative hemodialysis access pain management may be worth considering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, University of California, San Francisco, CA. Electronic address: timothy.copeland@ucsf.edu.
- New York University Grossman School of Medicine, New York, NY.
- Division of Vascular Surgery, University of California, Los Angeles, CA.
- Division of General Internal Medicine & Health Services Research, University of California, Los Angeles, CA.
- Department of Surgery, Kaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA.
- Division of Nephrology, University of California, San Francisco, CA.
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- Clinical and Translational Science Institute, University of California, Los Angeles
Zitieren
APA
Copeland, T. P., Nahm, W. J., Woo, K., Wisk, L. E., Dworsky, J. Q., Martin, E. J., & Ku, E. (2025). Opioid use patterns and persistent use after hemodialysis access surgery. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.05.207
Vancouver
Copeland TP, Nahm WJ, Woo K, Wisk LE, Dworsky JQ, Martin EJ, et al. Opioid use patterns and persistent use after hemodialysis access surgery. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.05.207
BibTeX
@article{Copeland2025,
author = {Copeland, Timothy P and Nahm, William J and Woo, Karen and Wisk, Lauren E and Dworsky, Jill Q and Martin, Emily J and Ku, Elaine},
title = {Opioid use patterns and persistent use after hemodialysis access surgery},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2025.05.207}
}
EUVIMED